DK Life Science Co., Ltd. (KOSDAQ:303810)

DK Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,297	2,403	3,424	1,381	6,553	20,435
Short-Term Investments	16,796	2,150	450	3,150	1,670	1,100
Cash & Short-Term Investments	18,092	4,553	3,874	4,531	8,223	21,535
Cash Growth	299.33%	17.54%	-14.50%	-44.90%	-61.82%	142.02%
Accounts Receivable	72,097	63,908	57,057	47,299	45,889	49,115
Other Receivables	1,578	1,414	1,163	1,122	2,101	796.66
Receivables	73,695	65,416	58,354	48,588	48,214	50,274
Inventory	32,341	42,258	39,647	29,346	19,980	13,013
Prepaid Expenses	177.88	234.55	55.05	59.63	45.75	21.48
Other Current Assets	3,234	3,196	990.08	1,330	2,941	1,971
Total Current Assets	127,540	115,658	102,920	83,854	79,403	86,816
Property, Plant & Equipment	64,425	64,700	64,749	65,106	54,218	27,378
Long-Term Investments	2	2,810	2,085	5,255	5,200	3,740
Other Intangible Assets	5,631	5,772	5,935	5,964	5,774	711.91
Long-Term Accounts Receivable	0	0	0	-0	-0	0
Long-Term Deferred Tax Assets	1,399	1,491	1,702	1,695	1,841	1,944
Other Long-Term Assets	4,296	1,227	1,737	2,560	1,459	407.4
Total Assets	203,293	191,658	179,129	164,434	147,894	120,997
Accounts Payable	22,259	28,212	24,259	18,270	14,808	14,622
Accrued Expenses	400.3	429.19	503.94	392.33	352.2	301.24
Short-Term Debt	20,700	22,000	22,600	16,100	13,000	4,600
Current Portion of Long-Term Debt	396.93	396.93	5,729	-	-	-
Current Portion of Leases	481.2	323.64	527.75	467.88	208.07	297.25
Current Income Taxes Payable	1,045	2,034	333.08	671.62	-	2,188
Other Current Liabilities	9,256	9,486	9,411	12,903	26,086	23,477
Total Current Liabilities	54,538	62,881	63,363	48,805	54,453	45,485
Long-Term Debt	22,305	22,404	18,750	25,000	10,000	-
Long-Term Leases	132.5	105.11	38.05	236.53	204.61	89.38
Other Long-Term Liabilities	1,053	1,043	230.67	238.65	435.51	588.99
Total Liabilities	78,028	86,433	82,382	74,280	65,094	46,618
Common Stock	7,996	6,966	5,629	5,629	5,629	5,629
Additional Paid-In Capital	81,557	64,808	31,809	31,809	31,809	31,809
Retained Earnings	36,467	34,217	31,972	27,805	23,566	17,708
Comprehensive Income & Other	-754.76	-766.15	-706.36	-114.63	-536.01	-696.07
Total Common Equity	125,265	105,224	68,704	65,129	60,469	54,451
Shareholders' Equity	125,265	105,224	96,747	90,154	82,800	74,379
Total Liabilities & Equity	203,293	191,658	179,129	164,434	147,894	120,997
Total Debt	44,015	45,230	47,645	41,804	23,413	4,987
Net Cash (Debt)	-25,923	-40,676	-43,771	-37,274	-15,190	16,549
Net Cash Growth	-	-	-	-	-	333.59%
Net Cash Per Share	-1889.56	-3171.15	-3907.82	-33296.60	-13570.02	14480.05
Filing Date Shares Outstanding	15.99	13.92	11.2	1.12	1.12	1.12
Total Common Shares Outstanding	15.99	13.92	11.2	1.12	1.12	1.12
Working Capital	73,002	52,776	39,557	35,049	24,950	41,330
Book Value Per Share	7832.96	7558.30	6133.81	58180.06	54019.63	48646.16
Tangible Book Value	119,634	99,452	62,769	59,165	54,695	53,739
Tangible Book Value Per Share	7480.83	7143.68	5603.93	52852.12	48861.86	48010.14
Land	9,849	9,857	9,857	11,737	11,737	2,407
Buildings	32,412	32,131	31,436	9,520	9,240	4,796
Machinery	51,179	50,824	48,467	27,318	24,767	19,980
Construction In Progress	3,343	2,968	622	40,849	30,800	20,583

Source: S&P Global Market Intelligence. Standard template. Financial Sources.